Month: May 2020

Phase 3 results comparing tislelizumab plus chemotherapy to chemotherapy alone met its primary endpointCompany to host investor conference call and webcast on ASCO clinical updates on Friday, May 29 at 8:00 p.m. ETCAMBRIDGE, Mass. and BEIJING, China, May 29, 2020 (GLOBE NEWSWIRE) — BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, today announced results from a Phase 3 clinical trial evaluating its anti-PD-1 antibody tislelizumab in combination with standard chemotherapy for the first-line treatment of patients with advanced squamous non-small cell lung cancer (NSCLC), presented at the 2020 American Society of Clinical Oncology (ASCO) Virtual Scientific Program.“The results...

The on-going dose escalation Phase 1 study has enrolled 44 patients with progressive, metastatic castration-resistant prostate cancer in 11 cohorts. Initial safety data showed that HPN424 is generally well-tolerated, and cytokine-related adverse events have been transient and manageable. Pharmacokinetic data supports weekly dosing and pharmacodynamic data supports T cell activation and target engagement consistent with the expected mechanism of action. Signals of clinical activity include multiple patients remaining on study for more than 24 weeks, and serum PSA declines. Management to host webcast and conference call to review the interim Phase 1 data and provide a pipeline update today at 4 p.m. ET /1 p.m. PT  SOUTH SAN FRANCISCO, Calif., May 29, 2020 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage...

VANCOUVER, British Columbia, May 29, 2020 (GLOBE NEWSWIRE) — SouthGobi Resources Ltd. (TSX: SGQ, HK: 1878) (“SouthGobi” or the “Company”) provides this bi-weekly default status report in relation to the management cease trade order dated May 15, 2020 (“MCTO”) granted by the British Columbia Securities Commission (“BCSC”) pursuant to National Policy 12-203 – Cease Trade Orders for Continuous Disclosure Defaults (“NP 12-203“).As disclosed in its announcements dated May 12, 2020 and May 17, 2020, the Company was advised by its external auditors (the “Auditors”) that they were unable to render an unmodified opinion on the Company’s annual consolidated financial statements for the year ended December 31, 2019 (the “2019 Financial Statements”) prior to the filing deadline of May 14, 2020, as they have not obtained sufficient...

On 28 May 2020, the Estonian Government decided that as of 1 June, citizens of 16 Schengen countries (Austria, the Czech Republic, Finland, France, Germany, Greece, Hungary, Iceland, Latvia, Liechtenstein, Lithuania, Norway, Poland, Slovakia, Slovenia and Switzerland) may enter Estonia without a quarantine obligation and in addition, citizens of 11 other European countries (Sweden, Belgium, Portugal, Malta, Luxembourg, Italy, Spain, the Netherlands, Denmark, Great Britain, Ireland) may enter the country, but must then remain in quarantine for two weeks. The Ministry of Foreign Affairs updates the list of countries whose citizens will be allowed to enter without a quarantine obligation every Friday according to the rate of infected persons in the countries of origin.The government’s decision will help to resume passenger transport...

Eesti Vabariigi valitsus otsustas 28.05.2020, et alates 1. juunist saavad 16 Schengeni riigist (Austriast, Tšehhist, Soomest, Prantsusmaalt, Saksamaalt, Kreekast, Ungarist, Islandilt, Lätist, Liechtensteinist, Leedust, Norrast, Poolast, Slovakkiast, Sloveeniast ja Šveitsist) saabuvad reisijad Eestisse siseneda ilma karantiinikohustuseta ja lisaks võivad riiki siseneda veel 11 Euroopa riigi (Rootsi, Belgia, Portugal, Malta, Luksemburg, Itaalia, Hispaania, Holland, Taani, Suurbritannia, Iirimaa) kodanikud, kes peavad seejärel jääma kaheks nädalaks karantiini. Välisministeerium uuendab igal reedel Eestisse lubatavate karantiinikohustuseta riikide nimekirja lähtudes lähteriikide nakatunute suhtarvust. Valitsuse otsus aitab taaskäivitada reisijate vedu Eesti-Soome laevaliinidel, kus alates 14. maist on olnud võimalik reisida ainult tööga seotud...

HOUSTON, May 29, 2020 (GLOBE NEWSWIRE) — Harvest Oil & Gas Corp. (OTCQX: HRSTD) (“Harvest” or the “Company”) today announced results for the first quarter of 2020.Key Highlights

– Data continue to show encouraging clinical activity alongside tolerable safety to deliver a potentially highly differentiated product profile –Conference call and webcast to be held Monday, June 1, 2020 at 8:30 am EDT / 1:30 pm BSTLONDON, May 29, 2020 (GLOBE NEWSWIRE) — Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced new data highlighting progress on AUTO3, the company’s CAR T cell therapy being investigated in the ALEXANDER study, a Phase 1/2 study in relapsed/refractory diffuse large B cell lymphoma (DLBCL), during the Annual Society of Clinical Oncology 2020 (ASCO20) Virtual Scientific Program beginning May 29.“Data from the ALEXANDER trial of AUTO3, a CD19/CD22 dual-targeting CAR T product candidate in DLBCL have shown...

Reference is made to the Stock Exchange release on 7 April 2020 about Agreements with lenders about restructuring of the Groups debt.Reference also to Stock Exchange releases about support from bondholders meetings on the 27 April 2020 and from Extraordinary General Meeting on 28 April 2020.The resolutions stated 31 May 2020 as the last day for entering into formal agreements. The documentation of the unified solution has taken longer time than the company expected.Yesterday, the company sent Notice of an Extraordinary General Meeting to be held on the 18 June 2020 to set a new timeframe for implementation of the debt restructuring.The company’s plan is to finalize the process as soon as possible after the 18 June 2020 subject to the General Meeting’s expected approval.Contacts:CEO Njål Sævik, +47 909 35 722CFO Arne Johan Dale, +47 909...

Det vises børsmelding 7. april 2020 om avtale med långivere om restrukturering av konsernets gjeld. Det vises også til børsmeldinger om support fra obligasjonseiermøter 27. april 2020 og fra Ekstraordinær generalforsamling 28. april 2020.Vedtakene fastsatte 31. mai 2020 som frist for å inngå de formelle avtalene.Dokumentasjonen av den omforente løsningen har tatt lenger tid enn det selskapet forventet.Det er sent innkalling til ny Ekstraordinær Generalforsamling den 18. juni for å fastsette en ny tidsramme for implementering av restruktureringen av gjelden.Det er selskapets ambisjon å gjennomføre implementeringen av avtalene snarest mulig etter 18. juni 2020, forutsatt generalforsamlingens forventede tilslutning.Kontakter:Adm dir Njål Sævik, +47 909 36 722Finansdir Arne Johan Dale, +47 909 87 706Denne opplysningen er informasjonspliktig...

MONTREAL, May 29, 2020 (GLOBE NEWSWIRE) — Mr. Michael Mueller, Chair of the Board of Directors of Laurentian Bank of Canada (the “Bank”), is pleased to announce the appointment of Mr. Nicholas Zelenczuk as an independent Director of the Bank.Mr. Zelenczuk has more than 35 years of experience in banking, capital markets and investment management and has held senior positions in several large corporations in Canada.“We are delighted to welcome Mr. Zelenczuk to the Board of Directors of the Bank. We are confident that his extensive experience in enterprise risk management, long-term strategy development and operations-based technology will make a significant contribution to the expertise and depth of our Board to the benefit the Bank.” commented Mr. Michael Mueller.With more than 3,100 employees guided by the values of proximity, simplicity...